期刊文献+

停经前与停经后年轻女性冠心病患者危险因素及冠状动脉病变特点比较

Comparison of risk factors,clinical and angiographic features in women with coronary artery disease aged under 50 before and after menopause
下载PDF
导出
摘要 目的探讨年龄在50岁以下的停经与未停经的女性冠状动脉粥样硬化性心脏病(冠心病)患者的危险因素、临床及冠状动脉造影特点。方法选取经临床及冠状动脉造影确诊的年龄50岁以下女性冠心病住院患者共173例,按月经情况分为停经组与未停经组,对比分析两组间冠心病危险因素、临床及冠状动脉造影特点。结果未停经组年龄小于停经组,差异有统计学意义[(44.5±5.6)岁vs.(48.4±2.1)岁,P<0.05];两组体质量比较,差异无统计学意义(P>0.05)。未停经组血脂异常及糖尿病患者比例明显多于停经组,差异有统计学意义(15.0%vs.0,P<0.05;62.1%vs.42.4,P<0.05);空腹血糖浓度高于停经组,差异有统计学意义[(6.27±2.30)mmol/L vs.(5.40±0.90)mmol/L,P<0.05]。未停经组高密度脂蛋白浓度低于停经组,差异有统计学意义[(1.21±0.31)mmol/L vs.(1.02±0.28)mmol/L,P<0.05],而两组其他血脂成分(血清总胆固醇、低密度脂蛋白、三酰甘油、载脂蛋白A及载脂蛋白B100浓度)比较,差异均无统计学意义(P>0.05)。两组尿蛋白阳性患者比例、血清尿酸及血清肌酐浓度比较,差异无统计学意义(P>0.05)。未停经组患者左前降支及其分支受累率明显高于停经组,差异有统计学意义(76.4%vs.51.5%,P<0.05);发生急性心肌梗死的患者比例也比停经组高,差异有统计学意义(26.4%vs.6.1%,P<0.05)。结论年龄50岁以下女性冠心病患者,未停经患者比停经患者年轻,有血脂异常及糖尿病等冠心病危险因素的患者比已停经患者多。未停经患者比已停经年轻女性冠心病患者高危,需要及时识别并积极诊治。 Objectives To investigate the risk factors,clinical and angiographic features in women with coronary artery disease(CAD) aged under 50 before and after menopause. Methods One hundred and seventy-three women with CAD aged under 50 were included and classified as pre-menopause group and post-menopause group. Differences in CAD risk factors,clinical and angiographic features between the two groups were analyzed. Results Patients in pre-menopause group were significantly younger than those in post-menopause group [(44.5±5.6) years vs.(48.4±2.1) years,P〈0.05 ],while with similar body weights(P〉0.05). There were much more patients with diabetes and dyslipidemia in premenopause group than in post-menopause group(15.0% vs. 0,P〈0.05; 62.1% vs. 42.4,P〈0.05) and serum glucose in pre-menopause group was significantly higher than that in post-menopause group [(6.27±2.30) mmol / L vs.(5.40±0.90)mmol / L,P〈0.05 ]. Serum concentration of high-density lipoprotein(HDL) was significantly lower in pre-menopause group than in post-menopause group [(1.21±0.31) mmol / L vs.(1.02±0.28) mmol / L,P〈0.05 ],while no significant difference as for other blood lipid components(total cholesterol,low-density lipoprotein,triglycerides,apolipoprotein A and apolipoprotein B100) was found between the two groups(all P〉0.05). Percentage of patients with positive urine protein value,urine and serum creatinine were similar between the two groups(P〉0.05). There were much more patients with diseased left anterior descending artery and suffered from acute myocardial infarction in pre-menopause group than in post-menopause group(76.4% vs. 51.5%,P〈0.05; 26.4% vs. 6.1%,P〈0.05). Conclusions Of female patients with CAD aged under 50,those who remain pre-menopausal are younger and with more CAD risk factors such as diabetes and dyslipidemia. These high-risk patients need to be screened and treated aggressively in the early stage.
出处 《岭南心血管病杂志》 2015年第1期43-46,共4页 South China Journal of Cardiovascular Diseases
关键词 冠状动脉疾病 冠状动脉造影 危险因素 停经 女性 coronary heart disease coronary angiography risk factors menopause female
  • 相关文献

参考文献18

  • 1WINGO P A, CALLE E E, MCTIERNAN A. How does breast cancer mortality compare with that of other cancers and selected cardiovascular diseases at different ages in U.S. women? [J]. J Womens Health Gend Based Med, 2000, 9(9): 999-1006.
  • 2FORD E S, CAPEWELL S. Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates [J]J Am Coil Cardiol, 2007, 50(22): 2128-2132.
  • 3贾亚丹,杨帆,赵洛沙.性激素水平与女性冠心病及同型半胱氨酸、纤维蛋白原的相关性研究[J].实用医学杂志,2013,29(1):67-68. 被引量:13
  • 4BERGER J S, ELLIOTF L, GALLUP D, et al. Sex differences in mortalityfollowingacntecoronarysyndromes[J]. JAMA, 2009, 302(8) : 874-882.
  • 5CARRABBA N, SANTORO G M, BALZI D, et al. In-hospital management and outcome in women with acute myocardial infarction (data from the AMI Florence Registry) [J]. Am J Cardiol, 2004, 94(9) : 1118 -1123.
  • 6HOCHMAN J S, MCCABE C H, STONE P H, et al. Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIM/ IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction[J]. J Am Coil Cardiol, 1997, 30(1) : 141-148.
  • 7LLOYD-JONES D, ADAMS R J, BROWN T M, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association [J]. Circulation, 2010, 121 (7) : e46-e215.
  • 8KANNEL W, HJORTLAND M, MCNAMARA P, et al. Menopause and risk of cardiovascular disease : the Framingham Study[J]. Ann Intern Med, 1976, 85(4) :447-452.
  • 9JACOBSEN B K, NILSSEN S, HEUCH I, et al. Does age at natural menopause affect mortality from ischemic heart disease.'? [J]. J Clin Epidemiol, 1997, 50(4): 475-479.
  • 10VAN DER SCHOUW Y, VAN DER GRAAF Y, STEYERBERG E, et al. Age at menopause as a risk factor for cardiovascular mortality[J]. Lancet, 1996, 347(9003) :714-718.

二级参考文献9

  • 1Scarabin-Carre V,Canonico M,Brailly-Tabard S. High level of plasma estradiol as a new predictor of ischemic arterial disease in older postmenopausal women;the three-city cohort study[J].J Am Heart Assoc,2012,(03):e001388.
  • 2Xing D,Nozell S,Chen Y F. Estrogen and mechanisms of vascular protection[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2009,(03):289-295.
  • 3Mosca L,Banka C L,Benjamin E J. Evidence-based guidelines for cardiovascular disease prevention in women:2007 update[J].Journal of the American College of Cardiology,2007,(11):1230-1250,230.
  • 4Fibrinogen Studies Collaboration,Danesh J,Lewington S. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality;an individual participant meta-analysis[J].Journal of the American Medical Association,2005,(14):1799-1809.
  • 5Karim R,Stanczyk F Z,Hodis H N. Associations between markers of inflammation and physiological and pharmacological levels of circulating sex hormonesin postmenopausal women[J].MENOPAUSE-THE Journal OF THE NORTH AMERICAN MENOPAUSE SOCIETY,2010,(04):785-790.
  • 6Miller A P,Xing D,Feng W. Aged rats lose vasoprotective and anti-inflammatory actions of estrogen in injured arteries[J].MENOPAUSE-THE Journal OF THE NORTH AMERICAN MENOPAUSE SOCIETY,2007,(02):251-260.
  • 7Harman S M,Vittinghoff E,Brinton E A. Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes[J].American Journal of Medicine,2011,(03):199-205.
  • 8胡威,郭志刚,陈君,周忠江,修建成.女性冠心病患者冠状动脉病变特点及相关危险因素分析[J].实用医学杂志,2009,25(8):1220-1222. 被引量:12
  • 9王燕.冠心病患者中脂蛋白(a)和同型半胱氨酸的变化[J].实用医学杂志,2010,26(9):1612-1613. 被引量:18

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部